These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 19646629)

  • 1. Editorial comment. Variations in International Prostate Symptom scores, uroflowmetric parameters, and prostate volume after (125)I permanent brachytherapy for localized prostate cancer.
    Sandhu JS
    Urology; 2009 Aug; 74(2):411; author reply 411-2. PubMed ID: 19646629
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial comment. Variations in International Prostate Symptom scores, uroflowmetric parameters, and prostate volume after (125)I permanent brachytherapy for localized prostate cancer.
    Macaluso JN
    Urology; 2009 Aug; 74(2):412; author reply 412-3. PubMed ID: 19646631
    [No Abstract]   [Full Text] [Related]  

  • 3. Variations in international prostate symptom scores, uroflowmetric parameters, and prostate volume after (125)I permanent brachytherapy for localized prostate cancer.
    Tanaka N; Fujimoto K; Hirao Y; Asakawa I; Hasegawa M; Konishi N
    Urology; 2009 Aug; 74(2):407-11. PubMed ID: 19376570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of the International Prostate Symptom score with urinary flow studies, and catheterization rates following 125I prostate brachytherapy.
    Martens C; Pond G; Webster D; McLean M; Gillan C; Crook J
    Brachytherapy; 2006; 5(1):9-13. PubMed ID: 16563992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ejaculatory function after permanent 125I prostate brachytherapy for localized prostate cancer.
    Huyghe E; Delannes M; Wagner F; Delaunay B; Nohra J; Thoulouzan M; Shut-Yee JY; Plante P; Soulie M; Thonneau P; Bachaud JM
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):126-32. PubMed ID: 19362236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technical acquisition and dosimetric assessment of iodine-125 permanent brachytherapy in localized prostate cancer: our first series of 100 patients.
    Tanaka N; Asakawa I; Kondo H; Tanaka M; Fujimoto K; Hasegawa M; Konishi N; Hirao Y
    Int J Urol; 2009 Jan; 16(1):70-4. PubMed ID: 19120529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients who have had permanent implant prostate brachytherapy.
    Cousins C; Cosset JM
    Radiother Oncol; 2006 Sep; 80(3):395. PubMed ID: 16934353
    [No Abstract]   [Full Text] [Related]  

  • 8. [The treatment of localized cancer of the prostate using radioactive iodine implants].
    Fradet Y; Laverdière J; Beaudoin L
    Union Med Can; 1985 Sep; 114(9):737-9. PubMed ID: 4060345
    [No Abstract]   [Full Text] [Related]  

  • 9. [Iodine-125 implantation in localized prostate cancer].
    Battermann JJ
    Ned Tijdschr Geneeskd; 1998 May; 142(21):1228-9. PubMed ID: 9627460
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term follow-up shows brachytherapy effective against prostate cancer.
    Zuboy J
    Curr Treat Options Oncol; 2000 Aug; 1(3):193-4. PubMed ID: 12061375
    [No Abstract]   [Full Text] [Related]  

  • 11. Prospective evaluation of quality of life after permanent prostate brachytherapy with I-125: importance of baseline symptoms and of prostate-V150.
    Vordermark D; Noe M; Markert K; Wulf J; Müller G; Bratengeier K; Beckmann G; Baier F; Guckenberger M; Schiefelbein F; Schön G; Flentje M; Baier K
    Radiother Oncol; 2009 May; 91(2):217-24. PubMed ID: 19136175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brachytherapy doses for prostate cancer customized to risk factors: is it more important "how much" or "where"? In regard to Stone et al. (Int J Radiat Oncol Biol Phys 2007;69:1472-1477).
    Oton CA; Oton F
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):962; author reply 962-3. PubMed ID: 18514795
    [No Abstract]   [Full Text] [Related]  

  • 13. Brachytherapy and teletherapy for carcinoma of the prostate. University of Missouri-Columbia protocol.
    Abadir R; Ross G; Weinstein SH
    Mo Med; 1983 Apr; 80(4):194-6. PubMed ID: 6855744
    [No Abstract]   [Full Text] [Related]  

  • 14. Interstitial Iodine-125 seed implantation in the management of prostate cancer: preliminary report at UAB.
    Kim RY; Bueschen AJ
    Ala Med; 1986 Jan; 55(7):27-33. PubMed ID: 3953335
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostate cancer: radiation seed implantation without open surgery.
    Gregory B; Van Valkenburgh J
    J Post Anesth Nurs; 1989 Dec; 4(6):373-6. PubMed ID: 2480442
    [No Abstract]   [Full Text] [Related]  

  • 16. Prostatorectal fistula 14 years following brachytherapy for prostate cancer.
    Davis JW; Schellhammer PF
    J Urol; 2001 Jan; 165(1):189. PubMed ID: 11125400
    [No Abstract]   [Full Text] [Related]  

  • 17. Urinary morbidity after 125I brachytherapy of the prostate.
    Henderson A; Bott SR; Sooriakumaran P; Laing RW; Langley SE
    BJU Int; 2004 Apr; 93(6):890. PubMed ID: 15050021
    [No Abstract]   [Full Text] [Related]  

  • 18. Urethral stone formation after permanent radioactive seed implant for prostate cancer.
    Steinmetz R; Barrett W
    Am J Clin Oncol; 2006 Aug; 29(4):424-5. PubMed ID: 16891876
    [No Abstract]   [Full Text] [Related]  

  • 19. [Urodynamics in the course of distant and interstitial radiotherapy for locally-advanced prostate cancer].
    Kaprin AD; Khalil Farzat M; Ivanov SA; Gafanov RA
    Vopr Onkol; 2009; 55(3):361-4. PubMed ID: 19670739
    [No Abstract]   [Full Text] [Related]  

  • 20. [A retrospective comparison of radical retropubic prostatectomy and of iodine-125 brachytherapy in localized prostatic carcinoma].
    Kovács G
    Strahlenther Onkol; 2000 Mar; 176(3):150. PubMed ID: 10742837
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.